Lisa G. Abbott, MD

Northern Nevada Endocrinology
Reno, Nevada, United States

Disclosure information not submitted.

Presentation(s):

• ORF16-07 - Palopegteriparatide Treatment in Adults with Hypoparathyroidism: Final Results of the Phase 3 PaTHway Trial

  Saturday, June 13, 2026
  2:45 PM - 3:00 PM CT

• ORF16-08 - Efficacy and Safety of Once-Weekly Canvuparatide in Patients with Hypoparathyroidism: Results from Avail, a Phase 2 Randomized Clinical Trial

  Saturday, June 13, 2026
  3:00 PM - 3:15 PM CT